Endocrine Responses to Critical Illness: Novel Insights and Therapeutic Implications
The DOI matches its Crossref record; 162 of the 164 references it cites were found in a registry or an index.
Abstract
CONTEXT: Critical illness, an extreme form of severe physical stress, is characterized by important endocrine and metabolic changes. Due to critical care medicine, survival from previously lethal conditions has become possible, but many patients now enter a chronic phase of critical illness. The role of the endocrine and metabolic responses to acute and prolonged critical illness in mediating or hampering recovery remains highly debated. EVIDENCE ACQUISITION: The recent literature on changes within the hypothalamic-pituitary-thyroid axis and the hypothalamic-pituitary-adrenal axis and on hyperglycemia in relation to recovery from critical illness was critically appraised and interpreted against previous insights. Possible therapeutic implications of the novel insights were analyzed. Specific remaining questions were formulated. EVIDENCE SYNTHESIS: In recent years, important novel insights in the pathophysiology and the consequences of some of these endocrine responses to acute and chronic critical illness were generated. Acute endocrine adaptations are directed toward providing energy and substrates for the vital fight-or-flight response in a context of exogenous substrate deprivation. Distinct endocrine and metabolic alterations characterize the chronic phase of critical illness, which seems to be no longer solely beneficial and could hamper recovery and rehabilitation. CONCLUSIONS: Important novel insights reshape the current view on endocrine and metabolic responses to critical illness and further clarify underlying pathways. Although many issues remain unresolved, some therapeutic implications were already identified. More work is required to find better treatments, and the optimal timing for such treatments, to further prevent protracted critical illness, to enhance recovery thereof, and to optimize rehabilitation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prolonged reduction of ACTH signaling within adrenocortical cells may result in adrenal atrophy [59].”
In the citing paper
“Post-mortem studies of patients who died after prolonged sepsis demonstrate reduced adrenal cortical size and changes in adrenal morphology in keeping with reduced exposure of the adrenal cortex to ACTH [59].”
In the citing paper
“In addition, feedback inhibition exerted by elevated circulating free cortisol, driven by ACTH-independent mechanisms and suppressed cortisol breakdown, can suppress ACTH [14,15,59].”
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 3×
“The study revealed that blood glucose control to a normoglycemic target increased mortality as compared with the intermediate level in the control group (116), subsequently explained by a 13-fold increase in hypoglycemia (117).”
BackgroundResultIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“In a second study performed in patients admitted to a medical ICU in Leuven, these morbidity benefits were confirmed (106).”
BackgroundAnnane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Acute skeletal muscle wasting in critical illness
Puthucheary, Z. A., Rawal, J., McPhail, M., Connolly, B., Ratnayake, G., Chan, P., Hopkinson, N. S., Padhke, R., Dew, T., Sidhu, P. S., et al. (2013) · JAMA · doi:10.1001/jama.2013.278481 · Cited by 2,103
ESPEN guidelines on parenteral nutrition: intensive care
Singer, P., Berger, M. M., Van den Berghe, G., Biolo, G., Calder, P., Forbes, A., Griffiths, R., Kreyman, G., Leverve, X., & Pichard, C. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.04.024 · Cited by 1,907
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
Early versus late parenteral nutrition in critically ill adults
Casaer, M. P., Mesotten, D., Hermans, G., Wouters, P. J., Schetz, M., Meyfroidt, G., Van Cromphaut, S., Ingels, C., Meersseman, P., Muller, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102662 · Cited by 1,696
Cited by
Items 101–104 of 104
Thyroid-Liver Axis: Mechanistic Insights and Clinical Implications
Parveen, N., Chittawar, S., Khandelwal, D., & Aggarwal, S. (2026) · Cureus · doi:10.7759/cureus.110637 · Cited by 1
“Importantly, these changes are often reversible with clinical recovery and these patients do not consistently benefit from TH replacement, underscoring the need for cautious interpretation and avoidance of unnecessary treatment in acutely ill patients [34,35].”
Dovbysh, N. Y., Gritsan, A. I., & Cheverkova, A. S. (2026) · General Reanimatology · doi:10.15360/1813-9779-2026-3-2678
Karayiannis, D., Yatsulava, A. E., Katsigianni, D., Poupouzas, G. I., Vrettou, C. S., Issaris, V., Botoula, E., Tzanela, M., Vassiliadi, D. A., Vassiliou, A. G., et al. (2026) · Nutrients · doi:10.3390/nu18142391
“…the hypothalamic–pituitary–adrenal (HPA) axis and alters peripheral hormone sensitivity, driving a transition from an adaptive catabolic state toward anabolic resistance, across acute, subacute and chronic phases with distinct neuroendocrine, inflammatory and mitochondrial signatures [7,10,11].”
Metadata
- Authors
- Boonen, E., & Van den Berghe, G.
- Affiliations
- KU Leuven (BE)
- Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, B-3000 Leuven, Belgium
- ORCID
- Boonen, Eva
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-05-01
- Volume
- 99
- Issue
- 5
- Pages
- 1569-1582
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2033465735
- Semantic Scholar
- 456d12374f8ae1aecbfea66025df59a549c01121
- Cited by
- 105
- References
- 164
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 9 · 2020: 9 · 2019: 4 · 2018: 8 · 2017: 14 · 2016: 13 · 2015: 11 · 2014: 3
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- critical illness, endocrine response, hypothalamic-pituitary-thyroid axis, hypothalamic-pituitary-adrenal axis, hyperglycemia, chronic critical illness, metabolic adaptation, rehabilitation, substrate deprivation, fight-or-flight response
- MeSH terms
- Humans, Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Thyroid Gland, Critical Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.